News

18 May, 2022
Research
Crescom participated in AWC 2022 in Seoul, the AI world congress.

(Photo: Crescom’s CEO Jae Joon Lee(right) explaining the company's solution at the exhibition booth to internal and external guests such as Heo Seong-wook, Director of Information and Communication Industry Promotion Agency, Seo Jeong-suk, People's Strength Councilor, Joanna Donerbart, Dutch Ambassador to Korea, and German Ambassador to Korea Michael Reifenstull. ⓒ Crescom Co., Ltd.)

 Crescom Co., Ltd. (CEO Jae Joon Lee) specialized in artificial intelligence analysis solutions for musculoskeletal medical data announced that it participated in the 7th AWC 2022 in Seoul exhibition on May 12th.

 This event, co-hosted by the Information and Communication Industry Promotion Agency (NIPA), Digital Chosun, and The AI, under the theme of ‘Meta Health, The Next-Gen of Healthcare’, predicted the medical industry developing based on advanced technology.

 NIPA President Huh Seong-wook, National Assembly Member Seo Jeong-sook, Dutch Ambassador to Korea Joana Donerbart, German Ambassador to Korea Michael Reifenstul, Yongin Severance Hospital Director Choi Dong-hoon, Bundang Seoul National University Hospital Director Paik Nam-jong, and Kakao Healthcare CEO Hwang Hee attended the event. They experienced solution demonstrations of participating companies and had time to communicate with companies.

 At this event held at the 2nd Pangyo Techno Valley Metaverse Hub, exhibition booths of Crescom, National Cancer Center, Coreline Soft, British Embassy in Korea, Medical IP, Neurofit, Seoul National University Bundang Hospital, and JLK were prepared. The companies offered to experience this grafted medical device software.

 Crescom demonstrated 'MediAI-BA', a hybrid growth plate inspection AI solution that supplements the shortcomings of the existing bone age reading methods, GP and TW3, and integrates only the advantages with patented technology, and ‘MediAI’FX’, an artificial intelligence fracture detection solution.

 ‘MediAI-BA’ has been confirmed to be useful in the medical field in clinical trials for approval by the Ministry of Food and Drug Safety, and has greatly improved the efficiency and accuracy of analysis of the age of growth plates in children in more than 100 hospitals in Korea.
 ‘MediAI-FX’ is a wrist fracture detection solution that can detect scaphoid fractures that are difficult to detect but cause serious sequelae when left unattended.

 Crescom CEO Jae Joon Lee said, “We are delighted to be able to present our solutions to you by participating in an event where the latest medical device companies with the latest technologies such as AI have gathered.” He said, "With the artificial intelligence medical device software developed so far, we want to help you to perform fast and accurate medical actions in the clinical field, and we will do our best to advance into the global market so that it can be widely used in overseas markets."